Concepedia

Jo Vandercappellen

JV

8

Publications

443

Citations

8

H-Index

2007

Active since

Affiliations

KU Leuven(Current)

Rega Institute for Medical Research

University of Brescia

Université Libre de Bruxelles

Jo Vandercappellen is an author at KU Leuven specializing in colorectal cancer, tumor microenvironment, and vascular biology.

ORCID

Top concepts

Publications per year

2007–2023

8

Publications

8

Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration

Paul Proost, Anneleen Mortier, Tamara Loos et al. · Blood · 2007 · 132 citations · Full text

Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3

Sofie Struyf, Laura Salogni, Marie D. Burdick et al. · Blood · 2010 · 106 citations

Synergistic up‐regulation of MCP‐2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti‐tumoral effects

Sofie Struyf, Paul Proost, Jo Vandercappellen et al. · European Journal of Immunology · 2009 · 60 citations

The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth <i>In vivo</i>

Jo Vandercappellen, Sandra Liekens, Annelies Bronckaers et al. · Molecular Cancer Research · 2010 · 42 citations · Full text

Stimulation of angiostatic platelet factor-4 variant (CXCL4L1/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6/GCP-2) in normal and tumoral mesenchymal cells

Jo Vandercappellen, Sam Noppen, Hannelien Verbeke et al. · Journal of Leukocyte Biology · 2007 · 33 citations

Rows per page

1–5 of 8